Avalo Therapeutics, Inc. (AVTX) — Analyst estimates
Consensus analyst estimates for Avalo Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 0 | -0.65 | 3 |
| 2027 | 0 | -0.81 | 2 |
| 2028 | 13.88K | -2.86 | 6 |
| 2029 | 11.05M | -2.43 | 4 |
| 2030 | 106.46M | -1.31 | 2 |
Consensus analyst estimates by fiscal year.